tiprankstipranks
Advertisement

FTKI - ETF AI Analysis

Compare

Top Page

FTKI

First Trust Small Cap BuyWrite Income ETF (FTKI)

Rating:73Outperform
Price Target:
FTKI, the First Trust Small Cap BuyWrite Income ETF, has a solid overall rating, mainly supported by strong holdings like AstraZeneca and Jones Lang LaSalle, which benefit from robust financial performance, positive earnings calls, and strategic growth initiatives. Other contributors such as Credo Technology Group and Southern Copper add to the fund’s appeal with good momentum and growth outlooks, though high valuations and some operational or cost risks are present. Weaker names like Etsy, with financial instability and bearish trading signals, slightly hold back the rating, and investors should also be aware that several holdings face valuation concerns and periods of short-term technical weakness.
Positive Factors
Strong Recent Performance
The ETF has shown positive returns over the past month, three months, and year-to-date, indicating solid recent momentum.
High-Contributing Top Holdings
Several of the largest positions, such as Argan, MasTec, and Amkor, have delivered strong gains, helping support the fund’s overall performance.
Broad Sector Diversification
Holdings spread across financials, technology, industrials, consumer cyclical, energy, health care, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Single-Country Concentration
With essentially all exposure in U.S. stocks, the ETF offers little geographic diversification and is heavily tied to the U.S. market.
Notable Lagging Holdings
Some meaningful positions, including Veeva Systems and Check Point, have shown weak year-to-date performance, which can drag on the fund’s results if the trend continues.

FTKI vs. SPDR S&P 500 ETF (SPY)

FTKI Summary

The First Trust Small Cap BuyWrite Income ETF (FTKI) invests in a wide mix of smaller U.S. companies and aims to provide both income and growth. It doesn’t track a single index, but it focuses on small-cap stocks across many sectors like financials, technology, and industrials. Well-known holdings include AstraZeneca and Veeva Systems. FTKI uses an options strategy to generate extra income, which may appeal to investors looking for regular payouts plus long-term growth potential from smaller companies. However, it can still go up and down with the market and may be more volatile than funds focused on larger, more established companies.
How much will it cost me?The First Trust Small Cap BuyWrite Income ETF (FTKI) has an expense ratio of 0.85%, which means you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because the ETF uses an actively managed buy-write strategy to generate income, which typically involves more complex management compared to passively managed funds.
What would affect this ETF?FTKI's focus on U.S. small-cap companies and its buy-write strategy could benefit from a strong U.S. economy and rising demand for innovative small-cap stocks in sectors like technology and healthcare. However, challenges such as higher interest rates or economic slowdowns could negatively impact small-cap companies, which are often more sensitive to market volatility. Additionally, regulatory changes or sector-specific disruptions in industries like financials or consumer cyclical could influence the ETF's performance.

FTKI Top 10 Holdings

FTKI’s story is all about small-cap U.S. names where a handful of winners are doing the heavy lifting. Engineering and infrastructure plays like Argan and MasTec are rising smartly, giving the fund a solid industrial backbone, while chip-related Amkor and networking player Credo are adding extra spark from the tech side. Southern Copper has been a steady metal workhorse, but software names Veeva Systems and Check Point are losing steam and quietly tugging on returns. Overall, the ETF leans into U.S. small caps with a tilt toward financials, tech, and industrials.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Argan3.07%$728.00K$8.80B227.28%
73
Outperform
Sterling Infrastructure2.51%$595.09K$23.08B302.53%
71
Outperform
MasTec2.34%$556.06K$30.36B157.86%
74
Outperform
Credo Technology Group Holding Ltd1.95%$464.06K$33.75B218.18%
77
Outperform
Amkor1.89%$449.07K$16.98B252.22%
69
Neutral
Jones Lang Lasalle1.66%$393.15K$13.59B36.25%
79
Outperform
Southern Copper1.47%$348.41K$145.25B105.55%
73
Outperform
Scorpio Tankers1.41%$333.87K$4.23B104.28%
75
Outperform
AstraZeneca1.39%$330.14K$290.45B35.01%
80
Outperform
Credicorp1.38%$328.68K$26.51B68.28%
73
Outperform

FTKI Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
19.31
Positive
100DMA
19.08
Positive
200DMA
18.25
Positive
Market Momentum
MACD
0.03
Positive
RSI
49.20
Neutral
STOCH
4.46
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FTKI, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 19.55, equal to the 50-day MA of 19.31, and equal to the 200-day MA of 18.25, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 49.20 is Neutral, neither overbought nor oversold. The STOCH value of 4.46 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FTKI.

FTKI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$23.69M0.86%
73
Outperform
$94.43M0.75%
70
Neutral
$63.22M0.61%
64
Neutral
$59.19M0.64%
66
Neutral
$25.73M0.49%
65
Neutral
$24.75M0.74%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FTKI
First Trust Small Cap BuyWrite Income ETF
19.46
2.94
17.80%
AFSM
First Trust Active Factor Small Cap ETF
SYZ
Lazard US Systematic Small Cap Equity ETF
RUSC
US Small Cap Equity Active ETF
ESSC
Eventide Small Cap ETF
ALIL
Argent Focused Small Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement